www.statnews.com FDA scolds Merz over 'misleading' Instagram posts featuring interior designer Nate Berkus For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz Pharmaceutical rival to Botox. 
www.statnews.com Student group that ranked med schools over industry conflicts votes to accept pharma funding An organization devoted to educating future doctors about conflicts of interest will now accept industry funding due to financial stress, prompting outrage from former members. 
www.statnews.com Biosimilars haven't always yielded lower out-of-pocket costs for patients, study finds The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise. 
www.statnews.com Colombia issues a compulsory license for an HIV medicine and 'plants a flag for global health... “Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen. 
www.statnews.com Pharma companies and their allies seek to exempt orphan drugs from state pricing limits As more states create dedicated boards to cap the costs of medicines, some drugmakers and their allies are pushing back with a controversial tactic.